Related Experiment Video
Updated: Feb 2, 2026

Quantifying Learning in Young Infants: Tracking Leg Actions During a Discovery-learning Task
Published on: June 1, 2015
Two decades with omalizumab: what we still have to learn
Cristoforo Incorvaia1, Marina Mauro2, Elena Makri1
1Cardiac/Pulmonary Rehabilitation, ASST Pini/CTO, Milan, Italy, cristoforo.incorvaia@gmai.com.
Abstract:
From its availability for clinical use nearly two decades ago for severe asthma, omalizumab has gained strong evidence of efficacy and safety in the treatment of severe asthma not controlled by standard-of-care therapy. It has been acknowledged by Global Initiative on Asthma guidelines as add-on therapy against severe uncontrolled asthma. Thanks to controlled trials supporting its efficacy, omalizumab has also been licensed for the treatment of chronic spontaneous urticaria. The optimal duration of treatment in either disease has not been established. Despite its high price, omalizumab appears to be cost-effective in severe uncontrolled asthma as well as in chronic urticaria. The literature suggests a wide range of applications for omalizumab in various disorders regardless of allergic or non-allergic pathophysiology.
Related Concept Videos
Avoidance Learning and Learned Helplessness
Avoidance learning occurs when an organism learns that a specific behavior can prevent an unpleasant outcome. For example, a student who receives a bad grade may start studying harder to avoid future poor grades. This behavior persists even when the negative outcome is no longer present. Avoidance learning is powerful because it maintains behavior in the absence of the...
Associative Learning
Classical conditioning, also known...
Purposive Learning
Observational Learning
Learning Disabilities
Dyslexia
Dyslexia is a...
Introduction to Learning
In contrast to learned behaviors, unlearned behaviors such as crying, sexual...

